Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta. General Subjects|March 11, 2018
Turning off NADPH oxidase-2 by impeding p67phox activation in infected mouse macrophages reduced viral entry and inflammationNathalie Lejal, Sandrine Truchet, Edna Bechor, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2013
Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virusNathalie Lejal, Bogdan Tarus, Edwige Bouguyon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 17, 2010
Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cellsRonan Le Goffic, Edwige Bouguyon, Christophe Chevalier, et al.
Frontiers in Immunology|March 18, 2020
The Composition of Circulating Leukocytes Varies With Age and Melanoma Onset in the MeLiM Pig Biomedical ModelFany Blanc, Armelle Prévost-Blondel, Guillaume Piton, et al.
Developmental and Comparative Immunology|June 28, 2016
Expanding the tools for identifying mononuclear phagocyte subsets in swine: Reagents to porcine CD11c and XCR1Charlotte Deloizy, Edwige Bouguyon, Even Fossum, et al.
Nutrients|January 21, 2023
An Isolate of Streptococcus mitis Displayed In Vitro Antimicrobial Activity and Deleterious Effect in a Preclinical Model of Lung InfectionElliot Mathieu, Quentin Marquant, Florian Chain, et al.
Veterinary Research|April 18, 2023
Screening antivirals with a mCherry-expressing recombinant bovine respiratory syncytial virus: a proof of concept using cyclopamineJenna Fix, Delphyne Descamps, Marie Galloux, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2016
Non-invasive epicutaneous vaccine against Respiratory Syncytial Virus: Preclinical proof of conceptPierre-Louis Hervé, Delphyne Descamps, Charlotte Deloizy, et al.
Frontiers in Immunology|October 19, 2018
Porcine Reproductive and Respiratory Syndrome Virus Type 1.3 Lena Triggers Conventional Dendritic Cells 1 Activation and T Helper 1 Immune Response Without Infecting Dendritic CellsElise Bordet, Fany Blanc, Mathieu Tiret, et al.
NPJ Vaccines|May 1, 2018
A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targetingTiphany Chrun, Sandra Lacôte, Céline Urien, et al.
Pageof 4